Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 24 weeks 1 day ago
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors 6/14/2024
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel 6/14/2024
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study 6/13/2024
Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial
Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial 6/13/2024
Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial
Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial 6/13/2024
Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases
Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases 6/13/2024
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups 6/13/2024
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report 6/13/2024
Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial
Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial 6/13/2024
Career Coach: How to Navigate 2 Job Interviews at the Same Company
Career Coach: How to Navigate 2 Job Interviews at the Same Company 6/13/2024
Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases
Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases 6/6/2024
Novo’s Ozempic, Wegovy to Face Stiff Generic Competition in China: Reuters
Novo’s Ozempic, Wegovy to Face Stiff Generic Competition in China: Reuters 6/6/2024
Amgen Phase III Win Positions Uplizna for Label Expansion in Rare Autoimmune Disease
Amgen Phase III Win Positions Uplizna for Label Expansion in Rare Autoimmune Disease 6/6/2024
BioSpace x DIA: Robust Integrated Regulatory Strategies
BioSpace x DIA: Robust Integrated Regulatory Strategies 6/6/2024
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report 6/6/2024
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees 6/6/2024
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow 6/6/2024
You’re More Than Your Job: Finding Self-Worth Outside of Work
You’re More Than Your Job: Finding Self-Worth Outside of Work 6/6/2024
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024
Opinion: Can Ketamine Be Safely Used at Home?
Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024
World Pharma News
- A new turning point in lung cancer treatment, inspired by mussels
- Developing a CRISPR therapy for muscular dystrophy
- A healthy diet is key to a healthy gut microbiome
- New study links millions of diabetes and heart disease cases globally to sugary drinks
- New method tracks the 'learning curve' of AI to decode complex genomic data